MedPath

Pediatric Hepatic Tumors

Recruiting
Conditions
Liver Tumor
Registration Number
NCT04274868
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Brief Summary

Centralized biological collection of multicentric origin, retrospective and prospective of biological samples (tissues and fluids) taken within the framework of the diagnostic and therapeutic management of children and adolescents with liver tumor, and supported in the centers of French Society for Childhood Cancers (SFCE) with associated clinical database.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
600
Inclusion Criteria
    • For inclusion in the clinical database:
    • Children and adolescents (≤18 years at diagnosis) suffering from a primary liver tumor diagnosed after 01/01/1990 and treated in France
    • Informed consent to the computerization of data signed by the patient or by parents or legal representatives if he is a minor.
    • For inclusion in the biological collection (CRB Paris Sud):
    • Additional criteria:
    • Availability of biological samples (tumor tissue, healthy tissue, plasma and / or serum).
    • Informed consent to the use of biological remains signed by the patient or by parents or legal representatives if he is a minor.
    • For the inclusion of deceased patients:
    • Obtaining consent or failing this, seeking non-opposition to the computerization of data (for inclusion in the database) and the use of biological remains (for inclusion in the biological collection) of the patient or both parents or the legal guardian if he is a minor.
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Establish a national bank of rare biological materialUp to 10 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Gustave Roussy

🇫🇷

Villejuif, Val De Marne, France

© Copyright 2025. All Rights Reserved by MedPath